Accelerating clinical research negotiation and contracting

Every site budget and contract, in-house and with your CROs, in one place.

Sira Sight brings study budgets, site negotiations, contracts and CRO oversight into one workspace, built on your own historical data and in your teams' languages.

Pharma and biotech sponsorsCROsResearch sites
Sira Oversight insights comparing in-house and CRO negotiations

Product views shown with illustrative data.

Why teams switch

Site budgets still live in spreadsheets, inboxes and CRO reports.

Sponsors negotiate thousands of site budgets a year, partly in-house and partly through CROs, across countries and languages. Most of that work happens outside any system.

Budgets rebuilt from scratch

Every study starts from a blank spreadsheet, while the history of what you actually paid sits unused in past contracts.

CRO negotiations out of sight

Deals agreed by CROs arrive as late tracker files. Price outcomes and cycle times are hard to compare with your own team's.

Global teams, local languages

Headquarters, country teams and CROs work in different languages and time zones, so decisions stall in email threads.

The Sira Sight apps

Four connected apps. Start with one.

Each app works on its own and shares the same studies, sites, people and history with the others.

Sira Budgets

Plan and negotiate

Plan and negotiate site budgets from your own history.

  • Ballpark estimates before a protocol exists
  • Schedule of events, country targets and ceilings
  • Line-by-line negotiation with suggested responses
  • Amendments, versions and payment schedules

Sira CTAs

Contract

Draft and track clinical trial agreements that match the budget.

  • Clause library by country
  • Budget exhibit from the agreed budget
  • Contract stages from draft to signature

Sira Oversight

In-house and CRO

See every negotiation, in-house and with your CROs, on the same measures.

  • One command center for all channels
  • CRO trackers in any format, standardised
  • Cycle time, price outcomes and SLAs over time
Coming soon

Sira Negotiator

Sponsors and sites

Exchange offers with sites in one shared space.

  • Site portal in the site's language
  • Rounds, comments and approvals on record
  • E-signature and hand-off to payments
One shared layer: your history, procedure and site libraries, people, messages, approvals and audit trail, in English and Japanese and more.
How it works

From past contracts to agreed budgets, in four steps.

1

Bring in your history

Upload past budgets and CTAs in any format and language, or import from your current grants system. Sira reads and standardises them.

2

Plan the study budget

Estimate early, build the schedule of events, and set targets and ceilings per country from what you have paid before.

3

Negotiate with sites

Your team or your CRO negotiates inside the same ceilings. Every round, exception and approval is recorded.

4

Oversee and pay

Track contracts, compare CROs with your in-house team, and check actuals against what was agreed.

Sira Budgets

Respond to every counter-offer in minutes.

Sira compares the site's ask with your offer, your ceilings and your history, and suggests a response for each line.

  • Ceilings from company, country, CRO and site rules
  • Exceptions routed for approval before anything is sent
  • Agreed budgets lock; changes open a new version
Counter-offer response with a suggested response per line
Sira Budgets · Ballpark

Know the cost before the protocol is final.

Pick the phase, therapeutic area, visits, patients and countries, and get a per-visit and per-patient ballpark in seconds, from your own history.

  • Mix countries and regions in one estimate
  • Every line says what it is based on: your history, a regional average or an estimate
  • Adjust with a reason, save, and compare scenarios
Ballpark estimator with countries and per-country estimates
Complexity and burden

See why one study costs more than another.

Sira scores every schedule of events for complexity, patient burden and site effort, so cost differences between studies, versions and scenarios have a clear explanation.

  • Patient hours and site hours per patient
  • Compared with your own past studies
  • Recalculated with every protocol amendment
Study complexity score, patient burden, site effort and procedures per patient
Global teams

One team in two languages, one workflow.

Japanese and English colleagues, and their CROs, work in the same threads and screens. Everyone reads in their own language, with the original one click away.

  • Interface in English, Japanese, Spanish, French and German
  • Messages translated as they are written
  • CRO users clearly marked, limited to their countries
Study thread with messages translated from Japanese
Sira Oversight

Your CROs and your team, on the same scorecard.

Compare cycle times, price outcomes and ceiling breaches by channel, study and country, over time, like for like.

  • CRO trackers mapped once, read automatically after
  • Change orders checked against actual activity
  • Alerts when trackers are late or deals stall
Trend of a negotiation measure by channel over six months
Portfolio

Every study, country and site at a glance.

From planning to active studies, see where your budgets stand and open any number to the list behind it.

Map of sites across studies
Why Sira Sight is different

AI-native, end to end, and built by people who know the work.

Most tools cover one step, in one language, for one team. Sira Sight connects the whole site agreement for everyone who negotiates it.

AI-native, not AI-added

Sira reads protocols, budgets, CTAs and CRO trackers in any format and language, suggests the next step, and shows the source for every suggestion. People stay in control of every decision.

End to end, connected

From the first ballpark to the agreed budget, the signed CTA, CRO oversight and payments: one platform, one data layer, no re-keying between tools.

Built by people who did the job

Our founders bring decades of experience in pharma, site budgets and payments, cost benchmarking and enterprise software, and have built and sold companies in this space.

Your history first

Estimates and ceilings come from what you have actually paid, by country and site, so every number can be traced and defended.

In-house and CRO, together

Your own negotiators and your CROs work from the same budgets and ceilings, and are measured the same way.

Multilingual by design

Documents, screens and conversations in each user's language, from Japanese site cost tables to bilingual approvals.

Who it's for

One platform, three sides of the table.

Budget office

Plan study budgets, set country ceilings and approve exceptions with a full audit trail.

Country teams

Negotiate in your own language with suggested responses and your site's history at hand.

Outsourcing leads

Hand off to CROs with clear ceilings and compare their results with your in-house team.

Negotiate for sponsors

Work inside the sponsor's ceilings, in your language, without re-keying budgets.

Fewer tracker reports

Send your tracker as it is; Sira maps it once and reads every update after.

Faster approvals

Exceptions go straight to the right sponsor approver, with the justification attached.

See your history

Understand what you agreed before, by sponsor and procedure.

Counter with confidence

Compare an offer with your own costs and spot work that is not paid for.

One place to agree

Sira Negotiator will give sites one portal for offers, comments and signature.

Team

Serial entrepreneurs with deep pharma technology experience.

Eric Gildenhuys

Eric Gildenhuys

Co-founder and CEO

Multiple executive roles; 2 exits, 1 public. More than 20 years in pharma and software.

Anca Copaescu

Anca Copaescu

Co-founder and President

Domain expert with more than 20 years in pharma.

Ketan Pandya

Ketan Pandya

Co-founder and CTO

AI and SaaS builder; venture backed, 2 exits. More than 20 years in start-up SaaS.

Partners

Better together with Clinical Maestro.

Sira Sight and Clinical Maestro have a commercial partnership, so sponsors can cover clinical business operations end to end: from study budgets, CRO sourcing and vendor governance to site budgets, site contracts and CRO oversight.

Clinical Maestro® by Strategikon Pharma is an AI-native platform for clinical business operations, orchestrating the work end to end with Maestro AI: study budgeting, bid comparison and contracting, vendor governance, change-order tracking, and costing and proposals for service providers. It serves biopharma sponsors, CROs and service providers.

Visit clinicalmaestro.com
Clinical MaestroStudy budgets · CRO bids and contracts · vendor governance · change orders
Sira SightSite budgets · site negotiation · CTAs · in-house and CRO oversight

One partner team for sponsors who want both, with joint demos on request.

Talk to us about the partnership
Security and trust

Designed for regulated data from day one.

Your budgets and contracts are commercially sensitive. Sira Sight is designed to keep them that way.

  • Your data stays yoursSeparate tenant for each customer; your history is never shown to other customers.
  • Encrypted throughoutEncryption in transit and at rest.
  • Role-based accessCROs and sites see only their studies, countries and sites.
  • Full audit trailEvery change, approval and export is recorded with who and when.
  • Data residency optionsRegional hosting for customers with local requirements.
  • Open APIsConnect to your CTMS, finance and grants systems.
Our vision

Four connected apps, from first budget to signed contract.

One platform for the whole site agreement: budget negotiation, CTA negotiation and CRO oversight, on one shared data layer, for your in-house team and your CROs alike. Next on our roadmap, Sira Negotiator brings live negotiation with sites into the same space.

Sira Budgets · budget negotiationSira CTAs · CTA negotiationSira Oversight · CRO oversightSira Negotiator · live negotiation (roadmap)
Contact us

See Sira Sight with your own studies.

Tell us a little about your team. We'll reply within one business day.

Partnership and investor conversations welcome
Reason for contacting us *
Something went wrong. Please try again in a moment.

* Required

Thank you. We've received your request and will be in touch within one business day.